UNSPSC 51172127: Elziverine

This classification denotes an antispasmotic agent with the molecular formula C32H37N3O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1I2BO46745, chemically known as 6,7-dimethoxy-4-((4-(o-methoxyphenyl)-1-piperazinyl)methyl)-1-veratrylisoquinoline but generally known as elziverine, which bears US NIH Compound Identifier 65839. European Medicines Agency schedules Elziverine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06498MIG.

UNSPSC 51172127 Elziverine is a Commodity code under which state and local governments procure specimen collection and drug-screening services for offender monitoring and criminal-justice supervision. The work encompasses staffing collection sites, administering immunoassay and confirmatory testing (LC/MS/MS or GC/MS), operating randomized notification systems, reporting results electronically, and offering alternative methodologies such as oral fluid and hair testing. Community supervision and corrections departments are the primary issuing bodies under this code, contracting with vendors to support probation, parole, and pretrial-supervision caseloads. Vendors must hold laboratory certifications from SAMHSA, the Texas Department of Public Safety, or CAP. Pricing is structured on a per-test basis with three service models — screening only, confirmation after screening, and screening with automatic confirmation of positives — with all costs including staffing, freight, delivery, and insurance bundled into the per-test rate and no additional surcharges permitted.

The Commodity code shows recent activity in Texas. Collin County Community Supervision and Corrections Department posted RFP 2026-327 on September 25, 2026, for offender specimen collection and drug testing services with proposals due July 23, 2026 at 2:00 p.m. The scope includes operating two collection sites in Plano and McKinney during standard business hours plus five Saturday sessions annually, with an annual testing volume of approximately 25,031 tests across five-panel and six-panel screens. The estimated contract value is $600,000 over two years with three optional one-year renewals, commencing September 1, 2026. The county may award in whole or in part to multiple vendors. Evaluation criteria weight vendor understanding and firm qualifications at 30 and 25 points respectively, client references at 15 points, and cost at 30 points, with optional Phase 2 demonstrations and interviews worth up to an additional 30 points. Price redetermination is limited to September 1 anniversaries and capped at 3.0 percent annual increases based on the medical Consumer Price Index. Funding derives from the Texas Department of Criminal Justice-Community Justice Assistance Division.